Purinethol
Purinethol Price range: $ 107,00 through $ 349,00
Back to products
Relpax
Relpax Price range: $ 27,00 through $ 152,00

Rebetol

Price range: $ 78,00 through $ 446,00

Rebetol is a potent antiviral medication primarily used to treat chronic hepatitis C virus (HCV) infections. It works by stopping the virus from spreading throughout the body, effectively lowering the viral load in the bloodstream. This medication is typically administered in combination with interferon-based products to achieve the best therapeutic results. The main objective of the treatment is to reduce the amount of HCV in the liver and improve the overall long-term health of the patient. Available in convenient capsule form, Rebetol provides a foundational component for comprehensive antiviral therapy regimens.

Active substance: ribavirin
SKU: Rebetol Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Rebetol should only be used under strict medical supervision by a licensed healthcare provider. It is prescribed as part of an FDA-approved combination regimen for the treatment of chronic hepatitis C virus infection. Under federal regulations in the United States, this medication is available by prescription only (Rx).

Rebetol contains the active drug ribavirin and is available in oral capsule and oral solution formulations. It is never effective as a standalone treatment (monotherapy) and must always be combined with other specified antiviral medications determined by your physician.

Attribute Details
Active ingredient Ribavirin
Primary purpose Chronic Hepatitis C combination therapy
Dosage form Oral capsule, oral solution
Route of administration Oral
Prescription status Prescription only (Rx)
Food requirement Must be taken with food

Safety Profile and Clinical Warnings

Important Precautions and Red Flags

Important precautions: Rebetol carries serious boxed warnings from the FDA due to significant risks of embryofetal toxicity and severe hemolytic anemia. Rebetol can cause major birth defects or fetal death. Therefore, it is strictly contraindicated in pregnant women and in male partners of pregnant women. Female patients of reproductive potential and male patients with female partners must utilize two reliable forms of effective contraception during therapy and for at least 6 months after completing treatment. Mandatory pregnancy tests must be performed prior to starting therapy, monthly during treatment, and monthly for 6 months post-treatment. Baseline hematologic testing is required because ribavirin causes dose-dependent hemolytic anemia, which can precipitate cardiac ischemia or worsen underlying cardiovascular disease.

Red flags: Patients receiving Rebetol combination therapy must be alert for severe, potentially life-threatening adverse reactions. You must seek emergency medical attention immediately if you notice any critical warning signs listed below.

Emergency Warning Sign Possible Clinical Complication Required Action
Chest pain, shortness of breath, rapid heart rate Severe anemia precipitating myocardial ischemia Seek emergency medical care immediately
Swelling of face, lips, tongue, or difficulty breathing Severe hypersensitivity / anaphylactic reaction Call 911 or visit emergency room
Severe fatigue, extreme paleness, dark urine Rapid onset severe hemolytic anemia Contact physician immediately
Sudden severe depression, thoughts of self-harm Severe neuropsychiatric adverse reaction Seek immediate psychiatric or emergency help
Unusual bleeding, severe bruising, high fever Bone marrow suppression / pancytopenia Seek immediate medical assessment

Adverse Reactions and Monitoring

Adverse reactions: The side effect profile of Rebetol combination therapy is extensive and requires close clinical oversight. The primary hematologic adverse reaction is hemolytic anemia, which typically occurs within the initial 1 to 4 weeks of starting treatment. Patients frequently experience constitutional symptoms including severe fatigue, headache, rigors, fever, insomnia, and myalgia. Gastrointestinal adverse effects such as nausea, anorexia, diarrhea, vomiting, and weight loss are common. Cutaneous reactions include generalized pruritus, rash, and dry skin. Neuropsychiatric side effects–including depression, anxiety, severe irritability, and concentration difficulties–must be evaluated promptly by a healthcare professional.

What happens in the body: Following oral administration, ribavirin is absorbed rapidly, reaching maximum plasma concentrations within 1.5 to 3 hours. Absolute bioavailability averages 45% to 64% due to first-pass metabolism. Co-administration with a high-fat meal increases total drug exposure (AUC) and peak concentrations. Ribavirin distributes extensively into body tissues and accumulates selectively inside red blood cells, where it remains trapped for the lifespan of the cell. Metabolism occurs in the liver, and elimination occurs through both hepatic metabolic pathways and renal excretion. The terminal elimination half-life is exceptionally long, ranging between 200 and 300 hours at steady state due to slow redistribution from non-plasma compartments.

Dosing, Interactions, and Practical Use

Dosing Schedule and Administration

Main uses: Rebetol is indicated for the treatment of chronic hepatitis C virus (HCV) infection in combination with peginterferon alfa-2b or interferon alfa-2b in patients 3 years of age and older with compensated liver disease. It is not indicated for monotherapy. Off-label use for non-HCV viral pathogens is not FDA-approved and must only occur under specialized clinical research or expert protocols.

How the drug works: Rebetol contains ribavirin, a synthetic nucleoside analogue with broad-spectrum antiviral activity against RNA viruses. Inside target host cells, ribavirin undergoes intracellular phosphorylation to form ribavirin triphosphate. This active metabolite inhibits viral RNA-dependent RNA polymerase, depletes intracellular guanosine triphosphate (GTP) pools, and induces hypermutation within the viral genome, ultimately inhibiting viral replication.

Dosing schedule: The prescribed dosage of Rebetol is determined based on patient body weight, renal function, viral genotype, and co-administered agents. The total daily dosage is divided into two separate doses taken twice daily (morning and evening). Rebetol capsules and oral solution must be taken with food to ensure adequate absorption. Treatment duration typically ranges from 24 to 48 weeks depending on therapeutic response and tolerability. Dose reductions or temporary suspensions are implemented if hemoglobin levels drop significantly.

If you skip a dose: If a dose is missed, take it as soon as remembered on the same day with food. If it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Never take two doses at the same time to compensate for a missed dose.

What to avoid while taking it: Rebetol should always be taken with food. Alcohol consumption must be completely avoided during treatment, as alcohol accelerates hepatic fibrosis, worsens liver injury, and impairs treatment efficacy. Avoid taking non-prescribed medications, over-the-counter drugs, or dietary supplements without approval from your prescribing clinician.

Drug Compatibility and Storage

Compatibility with other medicines: Rebetol exhibits life-threatening drug interactions with certain antiviral and immunosuppressive medications. Co-administration with didanosine is strictly contraindicated because ribavirin increases didanosine exposure, risking fatal lactic acidosis, severe hepatotoxicity, and peripheral neuropathy. Concomitant use with zidovudine increases the risk of severe anemia. Co-administration with azathioprine can cause severe bone marrow suppression and pancytopenia. Always inform your clinician of all active medications.

Storage and expiration: Store Rebetol capsules at controlled room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Store Rebetol oral solution at room temperature or under refrigeration between 2°C and 8°C (36°F and 46°F). Keep the bottle tightly closed and protected from heat and moisture. Dispose of unused or expired medication through authorized drug disposal programs.

Common questions

Why is frequent blood testing required while taking Rebetol?

Frequent blood tests are mandatory to monitor for hemolytic anemia, neutropenia, and impaired kidney function. Hemoglobin levels often drop significantly during the first month of therapy, requiring close medical surveillance and potential dose adjustments.

Why is pregnancy prevention so strict during and after treatment?

Ribavirin causes severe birth defects and embryofetal toxicity. Because the drug accumulates in tissues and has a terminal half-life of several hundred hours, two forms of effective contraception are required during therapy and for 6 full months after stopping the medication for both female patients and male patients with female partners.

Can Rebetol be taken on an empty stomach if I feel nauseous?

No. Rebetol must be taken with food because food significantly increases drug absorption and systemic exposure. Taking it on an empty stomach reduces its therapeutic effectiveness.

Is it safe to drive or operate machinery while taking Rebetol?

Rebetol combination therapy can cause severe fatigue, dizziness, and concentration difficulties. Patients should evaluate how the medication affects them before driving or operating heavy machinery.

What happens if hemoglobin levels drop too low during treatment?

If your hemoglobin drops below specific clinical thresholds (typically under 10 g/dL), your physician will reduce your Rebetol dose. If it drops below 8.5 g/dL, treatment must be temporarily or permanently discontinued.

This content is informational and does not replace a consultation with your doctor or pharmacist.

In accordance with FDA requirements.

Additional information
Dosage

200 mg

Package

10 caps

,

20 caps

,

30 caps

,

60 caps

,

90 caps

Ενεργός Ουσία